{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:38:50Z","timestamp":1792744730126,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"DOI":"10.1007\/s40290-026-00639-5","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:55:40Z","timestamp":1792742140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Operational Transformation in LATAM Medical Affairs: Building a Shared Regional Vision for Latin America Based on the AstraZeneca Spain Model"],"prefix":"10.1007","author":[{"given":"Inmaculada","family":"Iglesias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Marinich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Sforza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Grijalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"P\u00e9rez Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0944-6431","authenticated-orcid":false,"given":"Cecilia","family":"Marques-Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"639_CR1","unstructured":"MAPS Visionary Working Group. The Future of Medical Affairs 2030. Medical Affairs Professional Society [Internet] 2022. Last update: 2022. https:\/\/medicalaffairs.org\/position-paper-future-medical-affairs-2030\/. Accessed 30 Aug 2026."},{"key":"639_CR2","unstructured":"Algazy J, Garcia A, Ryan S, Westra A, Zemp A. A vision for medical affairs 2030: five priorities for patient impact. McKinsey & Company [Internet] 2023. Last update: 2023. https:\/\/www.mckinsey.com\/industries\/life-sciences\/our-insights\/a-vision-for-medical-affairs-2030-five-priorities-for-patient-impact#\/. Accessed 30 Aug 2026."},{"issue":"1","key":"639_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40290-024-00542-x","volume":"39","author":"I Iglesias","year":"2025","unstructured":"Iglesias I, Marinich JA, Anechina LR, Cortes M, Perez Dominguez A. Understanding the national healthcare ecosystem to position medical affairs as a strategic element: lessons learned from AstraZeneca Spain. Pharm Med. 2025;39(1):39\u201350. https:\/\/doi.org\/10.1007\/s40290-024-00542-x.","journal-title":"Pharm Med"},{"key":"639_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-025-00574-x","author":"A P\u00e9rez Dom\u00ednguez","year":"2025","unstructured":"P\u00e9rez Dom\u00ednguez A, Marinich J, Monteagudo G, Moreno C, Regadera L, Iglesias I. Pioneering the future of medical affairs: a strategic transformation to meet the Spanish healthcare ecosystem\u2019s evolving trends. Pharm Med. 2025. https:\/\/doi.org\/10.1007\/s40290-025-00574-x.","journal-title":"Pharm Med"},{"issue":"9974","key":"639_CR5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0140-6736(14)61646-9","volume":"385","author":"R Atun","year":"2015","unstructured":"Atun R, de Andrade LO, Almeida G, Cotlear D, Dmytraczenko T, Frenz P, et al. Health-system reform and universal health coverage in Latin America. Lancet. 2015;385(9974):1230\u201347. https:\/\/doi.org\/10.1016\/S0140-6736(14)61646-9.","journal-title":"Lancet"},{"issue":"1","key":"639_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40290-025-00551-4","volume":"39","author":"L Regadera Anechina","year":"2025","unstructured":"Regadera Anechina L, Iglesias I, Marinich JA, Diago J, Perez Dominguez A. The evolution of in-field medical affairs: introducing the strategic scientific advisor. Pharm Med. 2025;39(1):19\u201327. https:\/\/doi.org\/10.1007\/s40290-025-00551-4.","journal-title":"Pharm Med"},{"key":"639_CR7","unstructured":"PAHO. The urgency of investing in health systems in Latin America and the Caribbean to reduce inequality and achieve the Sustainable Development Goals. Economic Commission for Latin America and the Caribbean (ECLAC)\u2014Pan American Health Organization (PAHO) [Internet] 2024. Last update: 2024. https:\/\/www.paho.org\/sites\/default\/files\/2024-10\/2400869esespecialhealthreport-web.pdf. Accessed 31 Aug 2026."},{"key":"639_CR8","doi-asserted-by":"publisher","DOI":"10.1787\/7a7afb35-en","volume-title":"Health at a glance: Latin America and the Caribbean 2023","author":"OECD","year":"2023","unstructured":"OECD. Health at a glance: Latin America and the Caribbean 2023. Paris: OECD; 2023."},{"key":"639_CR9","unstructured":"Organization PAH. Progress in universal health in the Region of the Americas. Addressing unmet healthcare needs, gaps in coverage, and lack of financial protection, through primary health care [Internet]. (2024). https:\/\/iris.paho.org\/handle\/10665.2\/63086. Accessed 9th September 2026."},{"key":"639_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2025.101241","volume":"50","author":"E Bascolo","year":"2025","unstructured":"Bascolo E, Houghton N, Bennett S. Political economy of primary health care resilience in Latin America and the Caribbean: insights from the WB\/PAHO Commission recommendations. Lancet Reg Health Am. 2025;50:101241. https:\/\/doi.org\/10.1016\/j.lana.2025.101241.","journal-title":"Lancet Reg Health Am."},{"issue":"9974","key":"639_CR11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(14)61844-4","volume":"385","author":"AE Birn","year":"2015","unstructured":"Birn AE, Nervi L. Political roots of the struggle for health justice in Latin America. Lancet. 2015;385(9974):1174\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(14)61844-4.","journal-title":"Lancet"},{"issue":"1","key":"639_CR12","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462323002647","volume":"39","author":"S Garcia Marti","year":"2023","unstructured":"Garcia Marti S, Pichon-Riviere A, Augustovski F, Espinoza M. Real-world evidence: experiences and challenges for decision making in Latin America. Int J Technol Assess Health Care. 2023;39(1):e73. https:\/\/doi.org\/10.1017\/S0266462323002647.","journal-title":"Int J Technol Assess Health Care"},{"issue":"2","key":"639_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/jamia\/ocac228","volume":"30","author":"ST Liaw","year":"2023","unstructured":"Liaw ST, Godinho MA. Digital health and capability maturity models\u2014a critical thematic review and conceptual synthesis of the literature. J Am Med Inform Assoc. 2023;30(2):393\u2013406. https:\/\/doi.org\/10.1093\/jamia\/ocac228.","journal-title":"J Am Med Inform Assoc"},{"issue":"5","key":"639_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jhqr.2024.06.001","volume":"39","author":"J Escalada","year":"2024","unstructured":"Escalada J, Carretero Gomez J, Anguita M, de Sequera P, Garcia-Rio F, Davila I, et al. Enhancing the management of chronic diseases in clinical practice: the CARABELA methodology. J Healthc Qual Res. 2024;39(5):336\u20139. https:\/\/doi.org\/10.1016\/j.jhqr.2024.06.001.","journal-title":"J Healthc Qual Res"},{"issue":"1","key":"639_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40290-025-00592-9","volume":"40","author":"M Leal Beckouche","year":"2026","unstructured":"Leal Beckouche M, Resler Plat G, Marinich JA, Moreno C, Moreno M, Gostkorzewicz J, et al. The evolution of medical affairs central teams: shaping strategic action and driving healthcare transformation through scientific interaction. Pharm Med. 2026;40(1):9\u201318. https:\/\/doi.org\/10.1007\/s40290-025-00592-9.","journal-title":"Pharm Med"},{"key":"639_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-025-00575-w","author":"J Medina","year":"2025","unstructured":"Medina J, S\u00e1nchez-Covisa J, Nuevo J, Palacios B, Roncero A, Alegr\u00eda M, et al. Utilization of evidence blueprint initiative to transform capability development in AstraZeneca Spain. Pharm Med. 2025. https:\/\/doi.org\/10.1007\/s40290-025-00575-w.","journal-title":"Pharm Med"},{"issue":"2","key":"639_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40290-025-00599-2","volume":"40","author":"J Medina","year":"2026","unstructured":"Medina J, S\u00e1nchez-Covisa J, Nuevo J, Galvez-Fernandez M, Garc\u00eda A, Pimentel B, et al. Shaping the future of evidence generation: real-world data to drive healthcare transformation and patient-centered decisions. Pharm Med. 2026;40(2):95\u2013106. https:\/\/doi.org\/10.1007\/s40290-025-00599-2.","journal-title":"Pharm Med"},{"issue":"8","key":"639_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.semerg.2025.102586","volume":"51","author":"J Polo","year":"2025","unstructured":"Polo J, Rodriguez P, Mediavilla I, Perez A, Regadera L, Fitas E, et al. Redefining primary care: CARABELA-PC recomendations for the management of prevalent chronic diseases. SEMERGEN. 2025;51(8):102586. https:\/\/doi.org\/10.1016\/j.semerg.2025.102586.","journal-title":"SEMERGEN"},{"key":"639_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2025.101544","volume":"48","author":"C Almonacid","year":"2025","unstructured":"Almonacid C, Cosio BG, Munoz Gall X, Santina Vila M, Signes-Costa J, Velasco Garrido JL, et al. Optimising clinical trial management in Spain: the CARABELA-Clinical trials framework integrating healthcare models and subject experiences. Contemp Clin Trials Commun. 2025;48:101544. https:\/\/doi.org\/10.1016\/j.conctc.2025.101544.","journal-title":"Contemp Clin Trials Commun."},{"issue":"1","key":"639_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.opresp.2024.100378","volume":"7","author":"A Crespo-Lessmann","year":"2025","unstructured":"Crespo-Lessmann A, Carabela SASC. Enhancing the management of severe asthma in Spain: the CARABELA Initiative disclosed. Open Respir Arch. 2025;7(1):100378. https:\/\/doi.org\/10.1016\/j.opresp.2024.100378.","journal-title":"Open Respir Arch."},{"issue":"1","key":"639_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.opresp.2024.100387","volume":"7","author":"J de Miguel-Diez","year":"2025","unstructured":"de Miguel-Diez J, Diez Manglano J, Mediavilla I, Escudero L, Committee C-C, Appendix: The C-CSCcotfm. CARABELA-COPD: a novel approach for the transformation and improvement of the healthcare process in COPD management in Spain. Open Respir Arch. 2025;7(1):100387. https:\/\/doi.org\/10.1016\/j.opresp.2024.100387.","journal-title":"Open Respir Arch"},{"issue":"2","key":"639_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.rccl.2024.09.001","volume":"60","author":"\u00c1 Gonz\u00e1lez Franco","year":"2025","unstructured":"Gonz\u00e1lez Franco \u00c1, Soto JF, Mediavilla I, Leal M, Anguita M. CARABELA-HF: new frontiers in the optimization of heart failure clinical management in Spain. REC CardioClinics. 2025;60(2):145\u20138. https:\/\/doi.org\/10.1016\/j.rccl.2024.09.001.","journal-title":"REC CardioClinics"},{"key":"639_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14103378","author":"I Mediavilla","year":"2025","unstructured":"Mediavilla I, Anguita M, Gonzalez Franco A, Leal M, Carabela-Hf Scientific C, Soto JF. Healthcare models and quality indicators in the management of patients with heart failure in Spain: results from the CARABELA-HF initiative. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14103378.","journal-title":"J Clin Med"},{"issue":"6","key":"639_CR24","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.nefroe.2024.11.016","volume":"44","author":"B Quiroga","year":"2024","unstructured":"Quiroga B, Gorgojo JJ, Diago JI, Ruiz P, Committee C-CS. Toward optimization and excellence via a multidisciplinary care model for patients with chronic kidney disease in Spain: the CARABELA-CKD initiative. Nefrologia (Engl Ed). 2024;44(6):912\u20135. https:\/\/doi.org\/10.1016\/j.nefroe.2024.11.016.","journal-title":"Nefrologia (Engl Ed)"},{"issue":"2","key":"639_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40290-022-00419-x","volume":"36","author":"A Fulford-Smith","year":"2022","unstructured":"Fulford-Smith A, Leah E, Azroyan A, De Abadal M, Loew D, Hildemann S. Medical affairs transformation in specialty pharma: next-level collaboration at the core. Pharm Med. 2022;36(2):63\u20139. https:\/\/doi.org\/10.1007\/s40290-022-00419-x.","journal-title":"Pharm Med"},{"key":"639_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13151847","author":"J Gomes","year":"2025","unstructured":"Gomes J, Romao M. Evaluating maturity models in healthcare information systems: a comprehensive review. Healthcare (Basel). 2025. https:\/\/doi.org\/10.3390\/healthcare13151847.","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"639_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-018-0832-8","volume":"13","author":"M Jabbour","year":"2018","unstructured":"Jabbour M, Newton AS, Johnson D, Curran JA. Defining barriers and enablers for clinical pathway implementation in complex clinical settings. Implement Sci. 2018;13(1):139. https:\/\/doi.org\/10.1186\/s13012-018-0832-8.","journal-title":"Implement Sci"}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-026-00639-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-026-00639-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-026-00639-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:55:41Z","timestamp":1792742141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-026-00639-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":27,"alternative-id":["639"],"URL":"https:\/\/doi.org\/10.1007\/s40290-026-00639-5","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"24 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are employed by AstraZeneca.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data generated during the development of this article are included in this published version.","order":5,"name":"Ethics","label":"Availability of Data and Materials","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation and revision of this manuscript, the authors used Microsoft Copilot to support language editing, summarization, and refinement of selected sections of the text. The tool was used in an assistive capacity and did not replace the authors\u2019 scientific judgement or generate the conclusions of the article. The authors reviewed, verified, and edited all AI-assisted content and take full responsibility for the accuracy, originality, integrity, and final content of the publication.","order":7,"name":"Ethics","label":"Artificial intelligence disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed to the conception, design, implementation and analysis of the article. All authors critically reviewed, edited, and commented on the manuscript until the final version was obtained. All authors read and approved the final version of the manuscript.","order":8,"name":"Ethics","label":"Author contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}